Natus Sensory acquires the American firm TheraB Medical
Natus Sensory has acquired TheraB Medical, a US-based firm specializing in wearable phototherapy units for newborns.
The acquisition is meant to broaden entry to TheraB Medical’s SnugLit system, a wearable that treats neonatal jaundice, and additional broaden Natus Sensory’s initiative to supply complete, family-centered look after newborns.
Uncover B2B advertising that delivers
Mix enterprise intelligence and editorial excellence to succeed in engaged professionals throughout 36 main media platforms.
Extra data
SnugLit presents phototherapy for infants with jaundice. Designed as an toddler swaddle, it offers full physique protection in accordance with American Academy of Pediatrics tips and eliminates the necessity for eye safety usually required with typical phototherapy.
The transportable design permits better interplay with dad and mom and uninterrupted remedy, supporting continuity throughout totally different scientific settings.
Its portability makes it appropriate for family-centered care fashions in several healthcare settings.
Chris Mathia, CEO of TheraB Medical, stated: “This acquisition affirms TheraB’s mission to enhance outcomes for infants recognized with neonatal jaundice, whereas Natus Sensory’s international presence within the pediatric neighborhood permits broader entry to SnugLit’s modern phototherapy in hospital and scientific settings.”
Peter Reimer, CEO of Natus Sensory, stated: “At Natus Sensory, our imaginative and prescient for new child care is straightforward and deeply private: giving each child the very best begin in life. TheraB Medical’s wearable phototherapy innovation is strongly aligned with that imaginative and prescient.
“It enhances our present hospital-based options whereas increasing how and the place efficient care will be delivered – at all times primarily based on actual scientific wants and centered on bettering outcomes for newborns and their households.”
TheraB Medical acquired U.S. Meals and Drug Administration (FDA) approval for SnugLit final month.
The corporate is backed by a number of buyers together with BakerBridge Ventures, Angel Buyers, Gulf South Angels and Foster Lane Investments.
